تابعنا
AR
AR

أحد الأهداف الرئيسية لـ Life4me + - منع حالات الإصابة الجديدة بفيروس نقص المناعة البشرية والأمراض المنقولة جنسياً الأخرى والتهاب الكبد الوبائي والسل.

يساعد التطبيق على تأسيس اتصال مجهول بين الأطباء والمصابين بفيروس نقص المناعة البشرية. انها تسمح لك بسهولة تنظيم جدول الدواء الخاص بك وإعداد تذكير خفية وشخصية.

جميع الأخبار

أرشيف

✕
١٠ أكتوبر ٢٠١٧
4897
UNAIDS launches Coalition to step up commitment to HIV prevention

UNAIDS launches Coalition to step up commitment to HIV prevention

The Coalition will launch a HIV Prevention 2020 Road Map containing commitments and milestones, which will be reported on annually until 2020. The Road Map will form the basis of a country-led movement to scale up HIV prevention programmes.
١٠ أكتوبر ٢٠١٧
4951
The International AIDS Society mourns the passing of Amsterdam Mayor

The International AIDS Society mourns the passing of Amsterdam Mayor

“To stop the urban HIV epidemic, inclusivity is essential,” Mayor van der Laan said. His leadership vividly reflected this commitment to an open, transparent and participatory fight against HIV.
١٠ أكتوبر ٢٠١٧
5014
Durable end to the HIV/AIDS pandemic likely will require an HIV vaccine

Durable end to the HIV/AIDS pandemic likely will require an HIV vaccine

Despite remarkable gains in the treatment and prevention of HIV infection, development of an effective HIV vaccine likely will be necessary to achieve a durable end to the HIV/AIDS pandemic, according to a new commentary from Anthony S. Fauci, M.D., director of NIAID.
١٠ أكتوبر ٢٠١٧
5352
California lowers penalty for knowingly exposing partners to HIV

California lowers penalty for knowingly exposing partners to HIV

The law previously punished people who knowingly exposed or infected others with HIV by up to eight years in prison. This new legislation will lower jail time to a maximum of six months.
٩ أكتوبر ٢٠١٧
4831
Many MSM currently taking PrEP would switch to injectable forms of the therapy

Many MSM currently taking PrEP would switch to injectable forms of the therapy

Approximately a third of gay and bisexual men who are currently taking oral pre-exposure prophylaxis would prefer long-acting injectable PrEP should it become available.
٩ أكتوبر ٢٠١٧
4600
Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab

Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab

Theratechnologies Inc. today announced 48-week efficacy and safety results for ibalizumab in patients infected with multidrug resistant HIV-1.
٩ أكتوبر ٢٠١٧
5975
Gay Men May Be Able to Self-Check for Anal Cancer

Gay Men May Be Able to Self-Check for Anal Cancer

A recent study found that self- and partner exams were a fairly reliable way of identifying anal abnormalities that may be signs of cancer.
٩ أكتوبر ٢٠١٧
5389
ART Limits Appropriate Contraceptive Options for Women with HIV

ART Limits Appropriate Contraceptive Options for Women with HIV

Hormonal contraceptives with potential drug-drug interactions with antiretroviral therapy are commonly prescribed to women living with HIV, according to retrospective study findings.
٨ أكتوبر ٢٠١٧
5468
How UNAIDS “90-90-90” target looks in Russia today

How UNAIDS “90-90-90” target looks in Russia today

According to the Federal AIDS Center estimates, the UNAIDS "90-90-90" target in Russia looks like "64-33-75".
٦ أكتوبر ٢٠١٧
4366
Electronic systems in healthcare improve adherence to HIV treatment

Electronic systems in healthcare improve adherence to HIV treatment

Electronic systems in healthcare (e. g. mobile apps or websites) have a number of positive effects to people living with HIV
نحن نستخدم ملفات تعريف الارتباط على هذا الموقع لتعزيز تجربتك.
بالنقر فوق أي زر على هذا الموقع ، فإنك بذلك تمنح موافقتك على تعيين ملفات تعريف الارتباط.